First reported 11 hours ago -
Updated 11 hours ago -
Dr. Mikael Dolsten
, Pfizer's President of Worldwide Research, wrote a spirited response to my post. To be fair, Dr. Dolsten gave a number of reasons to justify this deal, including the need for breaking down silos that exist in pharmaceutical R&D, the ...
[Published Birmingham Star - 11 hours ago]